Weight based ribavirin with sofosbuvir and daclatasvir for 12 weeks for patients with Genotype 3 Hepatitis C and cirrhosis: An analysis of efficacy and long-term clinical outcomes.

著录项

• 来源
  《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共1页
• 作者

  Mazzarelli Chiara; Childs Kate; Montague Sarah; Dusheiko Geoffrey M.; Agarwal Kosh; Cannon Mary;

  展开▼
• 作者单位

  Kings Coll Hosp London Inst Liver Studies London England;

  Kings Coll Hosp London Inst Liver Studies London England;

  Kings Coll Hosp London Inst Liver Studies London England;

  Kings Coll Hosp London Inst Liver Studies London England;

  Kings Coll Hosp London Inst Liver Studies London England;

  Kings Coll Hosp London Inst Liver Studies London England;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 消化系及腹部疾病;
• 关键词